Alliance Boots sales soar
The pharmaceutical wholesale division was the best performer with revenues increasing by 23.6% to £13.94 billion. This was helped by the company’s acquisitions in the last year of Hadef Alliance and ANZAG.
Revenues for the health and beauty divisions were up by 1.7% to £7.62 billion and the Boots UK division saw like-for-like sales growth of 1.2%.
Stefano Pessina, executive chairman, said: "Alliance Boots continues to perform strongly, delivering a double digit growth in trading profit through a combination of organic growth and acquisitions, while at the same time reducing net borrowings.”
He continued: "In recent years we have made substantial capital investments, particularly in our Boots stores and supporting infrastructure. As a result, we have a strong platform for continuing growth in our core businesses and on which to build our next phase of growth, focused on international expansion."
"Looking to the year ahead, we are planning for consumer demand to be subdued and expect governments to continue to seek ways to contain growth in healthcare expenditure. In spite of this, we are confident about our future prospects both in the short and longer term. This comes from having a clear strategy, the right values, strong financial disciplines and dedicated teams throughout the group focused at all times on our customers."
The company’s chief executive, Andy Hornby, announced his departure from Boots last month in order to take time out from the corporate world.
Email this article to a friend
You need to be logged in to use this feature.
Please log in here